Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Axsome Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 174 | 4 | 188 | +18 |
| Shares | 21.6M | 3.19K | 25.7M | +4.10M (+19.0%) |
| Value | $826.7M | $122.3K | $1.15B | +$319.5M (+38.7%) |
4 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (41)
Institutions that held Axsome Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (23)
Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Pictet Asset Management SA | 353,521 | $13.5M |
| Cormorant Asset Management, LP | 205,000 | $7.85M |
| Mangrove Partners | 199,431 | $7.64M |
| Brookfield Asset Management Inc. | 64,846 | $2.48M |
| Employees Retirement System of Texas | 42,000 | $1.61M |
| Marshall Wace, LLP | 27,393 | $1.05M |
| Walleye Trading LLC | 22,506 | $862.0K |
| Panagora Asset Management Inc | 20,415 | $782.0K |
| Endurant Capital Management LP | 15,246 | $584.0K |
| Capital Fund Management S.A. | 13,133 | $503.0K |
| Quantamental Technologies LLC | 10,898 | $417.0K |
| Rafferty Asset Management, LLC | 9,734 | $373.0K |
| Quantbot Technologies LP | 8,178 | $313.0K |
| Y-Intercept (Hong Kong) Ltd | 7,715 | $295.0K |
| Kaizen Financial Strategies | 7,500 | $287.0K |
| Spire Wealth Management | 7,000 | $268.0K |
| D. E. Shaw & Co., Inc. | 6,762 | $259.0K |
| SG3 Management, LLC | 4,000 | $153.0K |
| Captrust Financial Advisors | 705 | $27.0K |
| Tilia Fiduciary Partners, Inc. | 136 | $6.00K |
| Farmers & Merchants Investments Inc | 102 | $4.00K |
| Financial Management Professionals, Inc. | 100 | $4.00K |
| State of Wyoming | 52 | $2.00K |
Not filed for Q3 2022 yet (4)
Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 2,279 | $87.3K |
| Private Capital Group, LLC | 633 | $24.0K |
| Urban Wealth Management, LLC | 181 | $7.00K |
| Cordasco Financial Network | 100 | $4.00K |